Is Summit Therapeutics Inc. overvalued?

Summit Therapeutics Inc. (SMMT) — key valuation metrics and fundamentals.

No verdict

Price

$15.61

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$12.45B

Dividend yield

0.0%

Return on equity

-204.3%

Sector

Healthcare

Fair value compares SMMT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks